Cited 0 times in
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.